Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Stratec SE | 2 | 0 | 0 | 0 | €41.30 | - | - |
| Gilead Sciences Inc | 11 | 1 | 1 | 0 | €70.80 | €85.27 | 20.444% |
| Fresenius SE & Co. KGaA | 3 | 0 | 0 | 0 | €31.97 | - | - |
| Vertex Pharmaceuticals Inc. | 54 | 2 | 4 | 0 | €458.50 | €440.93 | -3.832% |
| QIAGEN NV | 11 | 0 | 1 | 0 | €40.47 | €47.44 | 17.223% |
| Sartorius AG VZO | 5 | 0 | 2 | 0 | €232.80 | - | - |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.80 | €65.00 | -4.130% |
| Gerresheimer AG | 4 | 0 | 0 | 0 | €94.80 | - | - |
| Drägerwerk AG & Co. KGaA VZO | 4 | 0 | 1 | 0 | €48.75 | €60.00 | 23.077% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 6 | 0 | 0 | 0 | €43.30 | €95.00 | 119.400% |
| Fresenius Medical Care AG & Co KGaA ST | 3 | 0 | 0 | 0 | €37.39 | €50.00 | 33.726% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €144.40 | €165.00 | 14.266% |
| Sanofi S.A. | 3 | 0 | 0 | 0 | €96.27 | €99.50 | 3.355% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Pfizer Inc. | 29 | 4 | 2 | 0 | €27.58 | €41.29 | 49.701% |
| Johnson & Johnson | 39 | 1 | 4 | 0 | €147.02 | €195.31 | 32.843% |
| Merck & Co. Inc. | 30 | 1 | 0 | 0 | €115.60 | €124.97 | 8.108% |
| Align Technology | 21 | 2 | 5 | 0 | €211.40 | €315.49 | 49.237% |
| Biogen Inc. | 52 | 1 | 4 | 0 | €193.05 | €292.88 | 51.710% |
| Amgen Inc. | 25 | 0 | 2 | 0 | €309.90 | €304.65 | -1.695% |
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 4 | 0 | €989.00 | €1,034.6 | 4.614% |
| Intuitive Surgical Inc | 36 | 0 | 5 | 0 | €405.75 | €396.27 | -2.336% |